Literature DB >> 306869

Alpha1-antitrypsin phenotypes and lung function in a moderately polluted northern Ontario community.

D N Ostrow, J Manfreda, T Dorman, R M Cherniack.   

Abstract

To determine whether persons with intermediate value alpha1-antitrypsin phenotypes living in a polluted environment manifest significant abnormalities in lung function, a study was undertaken of an age-, sex- and smoking-stratified sample of 391 persons from the town of Fort Frances, Ont., which has elevated values of total dustfall, suspended particulates and hydrogen sulfide. Indices of pulmonary function were derived from the maximum expiratory flow and the single breath expiratory flow and the single breath expiratory nitrogen washout curves. The percentage frequency of the M, MS and MZ pheontypes was 91.7, 7.3 and 0.8, respectively. There was no significant difference between the M and MS groups as indicated by the nitrogen washout curve and maximum expiratory flow curve. There was no significant difference between the three MZ subjects and the M group. In both M and MS groups smokers displayed evidence of airflow obstruction when compared with nonsmokers. It would appear that, when compared with M subjects, persons with the MS phenotype living in a moderately polluted area show no changes in indicators of pulmonary function, including tests of early airway disease, that cannot be attributed to their smoking habit.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 306869      PMCID: PMC1818022     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  11 in total

1.  Letter: First International Alpha-Antitrypsin Pi System Workshop.

Authors:  M K Fagerhol; A M Johnson; R C Talamo
Journal:  Am Rev Respir Dis       Date:  1975-07

2.  Computer analysis of the single-breath nitrogen washout curve.

Authors:  N Craven; G Sidwall; P West; D S McCarthy; R M Cherniack
Journal:  Am Rev Respir Dis       Date:  1976-04

3.  Lung function in alpha1-antitrypsin heterozygotes (Pi type MZ).

Authors:  D M Cooper; V Hoeppner; D Cox; N Zamel; A C Bryan; H Levison
Journal:  Am Rev Respir Dis       Date:  1974-12

4.  Cardiopulmonary function in 1 -antitrypsin heterozygotes exposed to severe air pollution.

Authors:  A Szczeklik; K Stankowska; I Frydecka
Journal:  Am Rev Respir Dis       Date:  1973-02

5.  The mechanical properties of the lungs in intermediate deficiency of 1 -antitrypsin.

Authors:  D N Ostrow; R M Cherniack
Journal:  Am Rev Respir Dis       Date:  1972-09

6.  Serum Pi types in Norwegians.

Authors:  M K Fagerhol
Journal:  Acta Pathol Microbiol Scand       Date:  1967

7.  Serum alpha 1-antitrypsin variants. Prevalence and clinical spirometry.

Authors:  D R Webb; R W Hyde; R H Schwartz; W J Hall; J J Condemi; P L Townes
Journal:  Am Rev Respir Dis       Date:  1973-10

8.  Protease inhibitors in patients with chronic obstructive pulmonary disease: the alpha-antitrypsin heterozygote controversy.

Authors:  D W Cox; V H Hoeppner; H Levison
Journal:  Am Rev Respir Dis       Date:  1976-05

Review 9.  Relation of alpha-1-antitrypsin phenotype to the performance of pulmonary function tests and to the prevalence of respiratory illness in a working population.

Authors:  R B Cole; N C Nevin; G Blundell; J D Merrett; J R McDonald; W P Johnston
Journal:  Thorax       Date:  1976-04       Impact factor: 9.139

10.  A community study of the relation of alpha1-antitrypsin levels to obstructive lung diseases.

Authors:  J O Morse; M D Lebowitz; R J Knudson; B Burrows
Journal:  N Engl J Med       Date:  1975-02-06       Impact factor: 91.245

View more
  3 in total

1.  Respiratory symptoms and pulmonary function in 871 miners according to Pi phenotype: a longitudinal study.

Authors:  F Pierre; Q T Pham; J M Mur; N Chau; J P Martin
Journal:  Eur J Epidemiol       Date:  1988-03       Impact factor: 8.082

Review 2.  Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.

Authors:  C P Hersh; M Dahl; N P Ly; C S Berkey; B G Nordestgaard; E K Silverman
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

Review 3.  Updates on the COPD gene list.

Authors:  Yohan Bossé
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.